Literature DB >> 3004796

The anatomy and physiology of reverse cholesterol transport.

D Reichl, N E Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004796     DOI: 10.1042/cs0700221

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


× No keyword cloud information.
  9 in total

1.  A splice-junction mutation responsible for familial apolipoprotein A-II deficiency.

Authors:  S S Deeb; K Takata; R L Peng; G Kajiyama; J J Albers
Journal:  Am J Hum Genet       Date:  1990-04       Impact factor: 11.025

2.  Reverse cholesterol transport in the isolated perfused rat spleen.

Authors:  M A Mindham; P A Mayes; N E Miller
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

3.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

Authors:  J J Badimon; L Badimon; V Fuster
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 4.  Lymphatic transport of high-density lipoproteins and chylomicrons.

Authors:  Gwendalyn J Randolph; Norman E Miller
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

5.  L-Carnitine effects on chemical composition of plasma lipoproteins of rabbits fed with normal and high cholesterol diets.

Authors:  M Diaz; F Lopez; F Hernandez; J A Urbina
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

6.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

7.  Intercellular transport of lysosomal acid lipase mediates lipoprotein cholesteryl ester metabolism in a human vascular endothelial cell-fibroblast coculture system.

Authors:  G N Sando; G P Ma; K A Lindsley; Y P Wei
Journal:  Cell Regul       Date:  1990-08

Review 8.  Pharmacological intervention for altering lipid metabolism.

Authors:  N E Miller
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 9.  Lipids, lipoproteins, and coronary heart disease: implications for antihypertensive therapy.

Authors:  M D Feher; D J Betteridge
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.